Three-dimensional multimodal imaging for predicting early recurrence of hepatocellular carcinoma after surgical resection.

Journal: Journal of advanced research
Published Date:

Abstract

BACKGROUND: High tumor recurrence after surgery remains a significant challenge in managing hepatocellular carcinoma (HCC). We aimed to construct a multimodal model to forecast the early recurrence of HCC after surgical resection and explore the associated biological mechanisms.

Authors

  • Jie Peng
    School of Physical Education, Liupanshui Normal University, Liupanshui, China.
  • Jiaren Wang
    Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Hongbo Zhu
  • Pu Jiang
    Department of Health Management, Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • Ji Xia
    Department of Oncology, The Second Affiliated Hospital, Guizhou Medical University, Kaili 556000, China.
  • Hao Cui
    School of Information Engineering, Nanchang University, Nanchang 330031, China. hqucuihao@163.com.
  • Chang Hong
    State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, No. 1838, North Guangzhou Avenue, Baiyun District, Guangzhou, China.
  • Lin Zeng
    Department of Health Management, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Ruining Li
    Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Yan Li
    Interdisciplinary Research Center for Biology and Chemistry, Liaoning Normal University, Dalian, China.
  • Shengxing Liang
    School of Public Health, Southern Medical University, Guangzhou, 510515, China.
  • Qijie Deng
    Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • Huangying Deng
    General Department of Oncology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, China.
  • Hengtian Xu
    Department of Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China.
  • Hanzhi Dong
    Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330000, China. Electronic address: ndzhlyy1394@ncu.edu.cn.
  • Lushan Xiao
    Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li Liu
    Metanotitia Inc., Shenzhen, China.

Keywords

No keywords available for this article.